X-Sight, founded with technology developed at MIT and Massachusetts General Hospital, is dedicated to revolutionizing x-ray imaging through its innovative silicon field emission x-ray sources. The company's core mission is to provide better, safer, and more affordable x-ray imaging solutions. X-Sight's primary product is a compact, high-performance x-ray source designed for Computed Tomography (CT) applications, leveraging patent-pending technology to enhance imaging quality and efficiency.
Notable affiliations include the National Science Foundation (NSF), which awarded X-Sight an SBIR Phase I grant, recognizing the potential of their groundbreaking technology. The company's leadership comprises experts from MIT and Massachusetts General Hospital, ensuring a strong foundation in both research and practical application. X-Sight's impact is marked by its contribution to making advanced x-ray imaging more accessible and cost-effective, potentially transforming diagnostic practices in medical and industrial fields.
